Back

Use of idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. a multicentric experience in spain

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Treatment Heart Transplantation HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Maria Generosa Crespo-Leiro

CHUAC, A Coruna (Spain)

60 More presentations in this session

Presentation thumbnail
Ventricular arrhythmias in patients with continuous-flow left ventricular assist devices
Doctor A. Gkouziouta (Athens, GR)
Abstract
Presentation thumbnail
Treating advanced heart failure patients with biventricular assist devices in a low organ donation environment
Doctor A. Gkouziouta (Athens, GR)
Abstract
Presentation thumbnail
Coronary flow reserve estimated by 82-rubidium positron emission tomography predicts survival in long-term heart transplant recipients
Doctor L. Nelson (Copenhagen, DK)
Abstract
Presentation thumbnail
Is there a mortality weekend effect in cardiac transplantation?
Doctor R. Chand (Los Angeles, US)
Abstract Slides
Presentation thumbnail
Pregnancy in patients with pre-existing cardiomyopathy and in cardiac transplant patients
Doctor L. Vojtickova (Prague, CZ)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
Dealing with Heart Failure (again) after Cardiac Transplant
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Presentation
Hemochromatosis-induced cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources